When was Eclipse Bio founded?

Eclipse Bio was founded in 2017 and raised its 1st funding round within a year of its incorporation.

Where is Eclipse Bio located?

Eclipse Bio is headquartered in San Diego, United States. It is registered at San Diego, California.

Who is the current CEO of Eclipse Bio?

Peter Chu of Eclipse Bio. They have also founded 1 company.

How many employees does Eclipse Bio have?

As of Aug 31, 2026, the latest employee count at Eclipse Bio is 41.

Is Eclipse Bio a funded company?

Eclipse Bio is a funded company, having raised a total of $18.9M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 20, 2017.

When was the latest funding round of Eclipse Bio?

Eclipse Bio's latest funding was a $***** Series A round on Nov 05, 2025, with participation from 0 investor.

Where does Eclipse Bio rank among its competitors?

Eclipse Bio ranks 4th amongst 62 active competitors, of which 17 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Eclipse Bio, which secured $4.91M in Nov, 2025.

Who are the top competitors of Eclipse Bio?

Eclipse Bio's top competitors include Illumina, Arbor Biotechnologies and MGI. Among them, Eclipse Bio secured the most recent funding round in November, 2025.

Eclipse Bio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of cell-free immunoassay. The company have developed an eCLIP-seq method (high-throughput sequencing) which increases crosslinking and immunoprecipitation. It helps to identify RNA binding protein targets. The main components of each eCLIP include cancer cell line (HEK293T, K562), stem cells (human iPSC), differentiated stem cells (neurons, cardiomyocytes), and tissues (brain, heart).

Website: eclipsebio.com
Email ID: *****@eclipsebio.com
Registered Address: San Diego, California

Key Metrics

Founded Year

2017

Location

San Diego, United States

Stage

Series A

Total Funding

$18.9M in 7 rounds

Latest Funding Round

Series A, Nov 05, 2025, $*****

Investors

Alexandria & 3 more

Ranked

4^th among 62 active competitors

Employee Count

41 as on Aug 31, 2026

Investment & Acquisitions

Terrain Bio

Similar Companies

Illumina & 68 more

View Eclipse Bio's full profile

Eclipse Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Eclipse Bioinnovations, Inc. CIN: 822088549 , United States, Active	Dec 26, 999	-	14 (As on Dec 31, 2020)	-

Eclipse Bio has raised a total funding of $18.9M over 7 rounds. Its first funding round was on Sep 20, 2017. Eclipse Bio has 4 institutional investors.

Here is the list of recent funding rounds of Eclipse Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 05, 2025	4734683	Series A	1521134	4239393	8160244	3930942
Apr 25, 2025	7342001	Grant (prize money)	8047346	1381356	9057892	HHS
Jan 13, 2025	5804142	Grant (prize money)	3974495	4281130	4485673	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Eclipse Bio's funding rounds and investors

The founders of Eclipse Bio are Alexander Shishkin, Gene Yeo, Peter Chu and Eric Van Nostrand. Peter Chu is the CEO of Eclipse Bio.

Here are the details of Eclipse Bio's key team members:

Alexander Shishkin: Co-Founder of Eclipse Bio.
Gene Yeo: Co-Founder of Eclipse Bio.
Contact Info: 1 email address
Peter Chu: Co-Founder & CEO of Eclipse Bio.
Contact Info: 1 email address
Eric Van Nostrand: Co-Founder of Eclipse Bio.
Contact Info: 1 email address

View details of Eclipse Bio's Founder profiles and Board Members

Eclipse Bio's employee count trend

Eclipse Bio has 41 employees as of Aug 26. Here is Eclipse Bio's employee count trend over the years:

Uncover Eclipse Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Eclipse Bio include Illumina, Arbor Biotechnologies and MGI. Here is the list of Top 10 competitors of Eclipse Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
2nd	Arbor Biotechnologies 2016, Cambridge (United States), Series C	Provider of genomic technologies and drug discovery platform	$304M	TCG Crossover, Temasek & 27 others	65/100
3rd	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CPE & 13 others	64/100
4th	Eclipse Bio 2017, San Diego (United States), Series A	Developer of cell-free immunoassay	$18.9M	Alexandria, IGlobe Partners & 2 others	61/100
5th	Epredia 2019, United Kingdom, Unfunded	Developer of in-vitro diagnostic test for cancer	-	-	54/100
6th	Factor Bioscience 2011, Cambridge (United States), Seed	Developer of genomic technologies to treat disease and improve health	$1M	SBIR, HHS	54/100
7th	Octant 2017, Los Angeles (United States), Series B	Provider of human cell interaction platform for drug discovery	$115M	Andreessen Horowitz, Catalio Capital Management ... & 15 others	51/100
8th	Singleron 2018, Hagen (Germany), Series B	Developer of single-cell multi-omics platform for clinical research and molecular diagnosis	$84.5M	Yuanhe Holdings, Frees Fund & 13 others	50/100
9th	Genomic Vision 2004, Bagneux (France), Public	Nanotechnology for single DNA analysis for cancer and acute disease molecular diagnostics	$8.7M	Vesalius Biocapital Partners, Societe Generale ... & 2 others	47/100
10th	Genechem 2002, Shanghai (China), Series C	Products and services in molecular biology	$56.4M	Free Trade Zone Fund, Humanwell Healthcare ... & 2 others	46/100